Theratechnologies Investor Relations Material
Latest events
AGM 2025
Theratechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Theratechnologies Inc
Access all reports
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in cardiology, oncology, and women's health. The company primarily develops peptide-based therapeutics. Its product candidates include Onbrez Breezhaler, which is in Phase III clinical trial for the symptomatic relief of chronic obstructive pulmonary disease; and Theratears for Atopic Keratoconjunctivitis (MK), which is under Phase III clinical trial for the treatment of atopic keratoconjunctivitis. Theratechnologies Inc is headquartered in Montreal, Canada.
Key slides for Theratechnologies Inc
Corporate Presentation
Theratechnologies Inc
Corporate Presentation
Theratechnologies Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
TH
Country
🇨🇦 Canada